Page 5 - Conversion Labs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Conversion Labs Appoints Leading Telehealth Professional, Dr. Anthony Puopolo, as Chief Medical ... Conversion Labs, Inc.January 11, 2021 GMT NEW YORK, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc.  (NASDAQ: CVLB), a direct-to-consumer telemedicine company, has appointed licensed personal care and wellness physician and psychiatrist, Dr. Anthony Puopolo, to the new position of chief medical officer. ADVERTISEMENT Dr. Puopolo will be responsible for overseeing the company’s rapidly expa...

Conversion Labs Appoints Leading Telehealth Professional, Dr. Anthony Puopolo, as Chief Medical Officer NEW YORK, Jan. 11, 2021 — Conversion Labs, Inc. (NASDAQ: CVLB), a direct-to-consumer telemedicine company, has appointed licensed personal care and wellness physician and psychiatrist, Dr. Anthony Puopolo, to the new position of chief medical officer. Dr. Puopolo will be responsible for overseeing the company’s rapidly expanding network of state licensed physicians and ensuring that the company is delivering the highest quality of care. He will also work closely with Conversion Labs...

As mentioned in the stock exchange announcement on 27 October 2020, Restorsea has entered into an agreement to license Aquabeautine XL to the company Conversion Labs, which was listed on NASDAQ on 10 December 2020. Conversion Lab has today officially launched its new Veritas MD telecommunications health platform, which will roll out the new skincare brand Nava MD nationwide. Nava MD is based on Aquabeautine XL. The positive trend from Restorsea's commercialization of ABT's proprietary technology increases the likelihood that ABT will receive additional renewal payment and increased revenue f...